References
- EstlinEJContinuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanineCancer Treat Rev20012735136311908928
- HuennekensFMThe methotrexate story: a paradigm for development of cancer chemotherapeutic agentsAdv Enzyme Regul1994343974197942284
- ChabnerBARyanDPPaz-AresLGarcia-CarboneroRCalabresiPAntineoplastic agentsHardmanJGLimbirdLEGilmanAGoodman and Gilman’s The Pharmacological Basis of Therapeutics10th edNew York, NYMcGraw-Hill2001
- KaasgaardTAdresenTLJensenSSHolteHOJensenLTJorgensenKLiposomes containing alkylated methotrexate analogues for phospholipase A2 mediated tumor targeted drug deliveryChem Phys Lipids20091579410319094974
- DoddoliCChezOBarlésiFIn vitro and in vivo methotrexate disposition in alveolar macrophages: Comparison of pharmacokinetic parameters of two formulationsInt J Pharm200529718018915869851
- GurdagSKhandareJStapelsSMetherlyLHKannanRMActivity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell linesBioconjug Chem20061727528316536456
- LiYKwonGSMicelle-like structures of poly(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugatesColloids and Surfaces B: Biointerfaces199916217226
- SeoDHJeongYIKimDGJangMJJangMKNahJWMethotrexate-incorporated polymeric nanoparticles of methoxypoly(ethyleneglycol)- grafted chitosanColloids Surf B Biointerfaces20096915716319135342
- BaiKBLángOOrbánEDesign, synthesis, and in vitro activity of novel drug delivery systems containing tuftsin derivatives and methotrexateBioconjug Chem2008192260226918959436
- PaliwalRPaliwalSRMishraNMehtaAVyasSPEngineered chylomicron mimicking carrier emulsion for lymph targeted oral delivery of methotrexateInt J Pharm200938018118819576973
- PaliwalRRaiSVaidyaBEffect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic deliveryNanomedicine2009518419119095502
- RuckmaniKSivakumarMGaneshkumarPAMethotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinomaJ Nanosci Nanotechnol200662991299517048509
- HoYKSmithRGBrownMSGoldsteinJLLow-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cellsBlood19785210991114214187
- MasquelierMVitolsSPetersonCLow-density lipoprotein as a carrier of antitumoral drugs: in vivo of drug-human low-density lipoproteins complexes in miceCancer Res198646384238473731059
- MasquelierMVitolsSPalssonMMarsULarssonBSPetersonCOLow density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in bloodJ Drug Target2000815516410938525
- LundbergBPreparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathwayCancer Res198747410541083607752
- VitolsSAngelinBEricssonSGUptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapyProc Natl Acad Sci U S A199087259826022320578
- MaranhãoRCGaricocheaBSilvaELLlacerPDPileggiFJCChamoneDAFIncreased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia: a possible new strategy for the treatment of the diseaseBraz J Med Biol Res199225100310071342820
- MaranhãoRCGaricocheaBSilvaELPlasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemiaCancer Res199454466046668062260
- MaranhãoRCCésarTBPedroso-MarianiSRHirataMHMesquitaCHMetabolic behavior in rats of a non-protein microemulsion resembling low density lipoproteinLipids1993286916968377582
- HungriaVTMLatrilhaMCRodriguesDGBydlowskySPChiattoneCSMaranhaoRCMetabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and preliminary clinical study of LDE as drug vehicle for the treatment of the diseaseCancer Chemother Pharmacol200453516014574458
- RodriguesDGMariaDAFernandesDCImprovement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studiesCancer Chemother Pharmacol20055556557615726368
- ValdugaCJFernandesDCLo PreteACAzevedoCHMRodriguesDGMaranhaoRCUse of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposideJ Pharm Pharmacol2003551615162214738586
- Lo PreteACMariaDARodriguesDGValdugaCJIbanezOCMaranhãoRCEvaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsionJ Pharm Pharmacol20065880180816734981
- AdesACarvalhoJPGrazianiSRUptake of a cholesterol-rich emulsion by neoplastic ovarian tissuesGynecol Oncol200181848711426966
- GrazianiSRIgrejaFAFHeggRUptake of a cholesterol-rich emulsion by breast cancerGynecol Oncol20028549349712051880
- AzevedoCHCarvalhoJPValdugaCJMaranhãoRCPlasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinomaGynecol Oncol20059717818215790455
- DiasMLCarvalhoJPRodriguesDGGrazianiSRMaranhãoRCPharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancersCancer Chemother Pharmacol20075910511116699792
- PinheiroKVHungriaVTFickerESValdugaCJMesquitaCHMaranhaoRCPlasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDECancer Chemother Pharmacol20065762463016133527
- RosowskyAForschRAYuCSLazarusHBeardsleyGPMethotrexate analogues. 21. Divergent influence of alkyl chain on the dihydrofolate reductase affinity and cytotoxicity of methotrexate monoestersJ Med Chem1984276056096585550
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assayJ Immunol Methods19836555636606682
- LowryOHRosebroughNJFarrALRandallRProtein measurement with the Folin phenol reagentJ Biol Chem195119326527514907713
- SaitoHKawagishiATanakaMCoalescence of lipid emulsions in floating and freeze-thawing processes: examination of the coalescence transition state theoryJ Colloid Interface Sci199921912913410527578
- KabalnovATararaTArlauskasRWerrsJPhospholipids as emulsion stabilizers. 2. Phase behavior versus emulsion stabilityJ Colloid Interface Sci19961842272358954658
- PignatelloRSpampinatoGSorrentiVLipophilic methotrexate conjugates with antitumor activityEur J Pharm Sci20001023724510767601
- MaranhãoRCTavaresERPadovezeAFValdugaCJRodriguesDGPereiraMDPaclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbitAtherosclerosis200819795996618289548
- OfnerCM3rdPicaKBowmanBJChenCSGrowth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugatesInt J Pharm2006308909916361072